Norris Medicines Ltd.
BBSE:NORRIS15.00
INR
-0.20
(-1.32%)
ISIN
INE744C01029
Return %
Stock
S&P 500
1Y
-10.71
14.20
3Y
33.33
81.12
5Y
12.53
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Vimal Dhirendra Shah
- Full Time Employees
- 45
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Plot No. 801 Ankleshwar GU India 393002
- IPO Date
- Dec 15, 1993
- Website
- norrispharma.com
- Similar Companies
- Business
- Norris Medicines Limited manufactures and sells pharmaceutical formulations including nonsterile dosage forms such as tablets, capsules, liquid orals, and topical ointments, as well as injections and medicinal formulations across categories like antibiotics, anti-inflammatory and pain management products, antiemetics, nutrition supplements, gastro-intestinal treatments, cough and cold remedies, skin and allergy medications, antimalarials, diabetic drugs; the company, founded in 1990 and headquartered in Ankleshwar, Gujarat, India, operates two manufacturing plants in the GIDC Industrial Estate there and engages in contract manufacturing and license manufacturing for large multinational companies primarily serving the Indian healthcare sector.